BPC-157 has been widely studied in preclinical models for its potential role in: Tissue regeneration research (muscle, tendon, and epithelial cells), Gastrointestinal studies, exploring protective effects on gut lining and gastric integrity, Angiogenesis and vascular modulation research, Neuroprotective and anti-inflammatory investigations, These findings support continued interest in understanding BPC-157s interaction with cellular growth and repair pathways in experimental contexts
Takeaway: GLP-1s are unmatched for sheer weight loss on the scale
Now do you see where they got their name
Tsoko M, Beauseigneur F, Gresti J, et al
Semaglutide (Ozempic, Wegovy, Rybelsus) is the most prescribed GLP-1 receptor agonist worldwide, with proven efficacy across diabetes, obesity, and cardiovascular outcomes
The drug will likely come in pens with pre-measured doses, similar to other weight loss injections